Brief: Karen Massey To Become CEO Of Argenx
05/01/2026 06:01
Jan 5 (Reuters) - argenx SE ARGX.BR: ARGENX ANNOUNCES LEADERSHIP TRANSITION MARKING NEXT EVOLUTION OF GROWTH KAREN MASSEY TO BECOME CEO OF ARGENX TIM VAN HAUWERMEIREN TO BECOME CHAIRMAN OF ARGENX PETER VERHAEGHE RETIRES FROM ARGENX BOARD CHANGES SUBJECT TO SHAREHOLDER APPROVAL ON MAY 6, 2026 Source text: ID:nGNE4KDQ5Q Further company coverage: ARGX.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles